$10,000 of AMICUS THERAPEUTICS INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"newborn screening, prescription drug affordability"
You can find more data on corporate lobbying on Quiver Quantitative.
FOLD Insider Trading Activity
FOLD insiders have traded $FOLD stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $FOLD stock by insiders over the last 6 months:
- BRADLEY L CAMPBELL (President and CEO) has made 0 purchases and 4 sales selling 23,301 shares for an estimated $263,884.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
FOLD Hedge Fund Activity
We have seen 130 institutional investors add shares of FOLD stock to their portfolio, and 140 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 5,705,679 shares (-44.2%) from their portfolio in Q4 2024, for an estimated $53,747,496
- CITADEL ADVISORS LLC added 4,609,786 shares (+127.0%) to their portfolio in Q4 2024, for an estimated $43,424,184
- WELLINGTON MANAGEMENT GROUP LLP added 4,497,950 shares (+18.8%) to their portfolio in Q4 2024, for an estimated $42,370,689
- PERCEPTIVE ADVISORS LLC removed 3,811,504 shares (-13.6%) from their portfolio in Q4 2024, for an estimated $35,904,367
- VESTAL POINT CAPITAL, LP added 3,350,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $31,557,000
- JANUS HENDERSON GROUP PLC removed 2,940,177 shares (-46.4%) from their portfolio in Q4 2024, for an estimated $27,696,467
- MORGAN STANLEY removed 2,093,663 shares (-49.7%) from their portfolio in Q4 2024, for an estimated $19,722,305
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FOLD Analyst Ratings
Wall Street analysts have issued reports on $FOLD in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Cowen & Co. issued a "Buy" rating on 10/23/2024
- Bank of America Securities issued a "Buy" rating on 10/17/2024
- Jefferies issued a "Buy" rating on 10/11/2024
- Cantor Fitzgerald issued a "Underperform" rating on 10/11/2024
To track analyst ratings and price targets for FOLD, check out Quiver Quantitative's $FOLD forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
